Ardelyx Total Liabilities 2013-2024 | ARDX

Ardelyx total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Ardelyx Total Liabilities 2013-2024 | ARDX

Ardelyx total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$79.9B
Zoetis (ZTS)$70.1B
Daiichi Sankyo, - (DSNKY)$43.9B
Takeda Pharmaceutical (TAK)$43.7B
Sandoz Group AG (SDZNY)$20.6B
Merck (MKKGY)$18.3B
Astellas Pharma (ALPMY)$17.4B
United Therapeutics (UTHR)$17B
Summit Therapeutics (SMMT)$15.9B
Shionogi (SGIOY)$12.3B
Neurocrine Biosciences (NBIX)$11.4B
Corcept Therapeutics (CORT)$7.7B
Madrigal Pharmaceuticals (MDGL)$7.5B
Orion OYJ (ORINY)$7.4B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Stevanato Group S.p.A (STVN)$6.2B
Grifols, S.A (GRFS)$5.1B
Ionis Pharmaceuticals (IONS)$5B
Ono Pharmaceutical (OPHLF)$4.7B
Recursion Pharmaceuticals (RXRX)$4.2B
Crinetics Pharmaceuticals (CRNX)$3.4B
Catalyst Pharmaceuticals (CPRX)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.4B
Hypermarcas (HYPMY)$2.2B
Centessa Pharmaceuticals (CNTA)$2.1B
Soleno Therapeutics (SLNO)$2B
BioCryst Pharmaceuticals (BCRX)$1.9B
NewAmsterdam Pharma (NAMS)$1.8B
Evotec AG (EVO)$1.6B
Indivior (INDV)$1.5B